CCL2 and COVID-19: Besides supporting existing knowledge on especially IL-1ra, IL-6, IL-8, and MCP-1 in relation to COVID-19, our study has provided additional insight into lesser investigated chemokines associated with adverse outcomes in COVID-19 patients.